Panobinostat
-
- Applikation
- Inhibition (Inh)
- Verwendungszweck
- HDAC inhibitor
- Produktmerkmale
- A potent inhibitor of class I and II HDACs. Cotreatment with panobinostat and an HSP90 inhibitor caused synergistic apoptosis in human CML-BC and AML cells. A potent antimyeloma agent that overcomes drug resistance.
- Reinheit
- >98 %
- Chemical Name
- (E)-N-Hydroxy-3-(4-((2-(2-methyl-1H-indol-3-yl)ethylamino)methyl)phenyl)acrylamide
- Formel
- C21H23N3O2
- Löslichkeit
- Soluble in DMSO (up to 100 mg/ml) or in Ethanol (up to 5 mg/ml with warming).
-
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Powder
- Lagerung
- -20 °C
-
- Hintergrund
- LBH-589,Epigenetics,Apoptosis inducer,Protein deacetylase,Cell death,Cancer,Posttranslational modification,Chromatin
- Molekulargewicht
- 349.44
- CAS-Nummer
- 404950-80-7
-